Clinical Trial Update: Evaluating Muscle Weakness Improvement With Lorcaserin in ICU [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating lorcaserin for muscle weakness in ICU patients with sepsis was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Weakness
• Sepsis

Drugs mentioned

• Lorcaserin (lorcaserin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Muscle Weakness, Sepsis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-01-13